期刊文献+

B—NHL患者骨髓单个核细胞表面CD40、CD40L的表达及意义

Expressions and significance of CD40, CD40L in bone marrow mononuclear cell surface of patients with B - cell Non - Hodgkin's Lympboma
下载PDF
导出
摘要 目的探讨B细胞非霍奇金淋巴瘤(BcellNon—Hodgkin’SLymphoma,B—NHL)患者骨髓单个核细胞(BMMC)表面CIMO、CIM-0L的表达情况及变化规律,分析CIM0、CIMOI。表达与淋巴瘤发病、侵袭性及预后的关系及意义。方法采集20例初诊B—NHL伴有骨髓侵犯的患者(实验组)的骨髓标本及12例健康者(对照组)的骨髓标本,分离单个核细胞,采用直接荧光抗体标记,应用流式细胞仪检测细胞表面C1M0、CIMOL的表达情况。相关实验结果进行统计学比较。结果(1)B—NHL中CIM0阳性率(45.78±3.82)%显著高于正常对照组(13.99±2.20)%,P〈0.01;B—NHL中CIMOL阳性率(3.44±0.88)%显著低于正常对照组(10.64±1.03)%,P〈0.01;(2)B—NHL伴有骨髓侵犯的患者CIM0、CIMOL阳性率与病理类型、LDH值、全身症状呈显著相关,P〈0.05;(3)B—NHL伴有骨髓侵犯的患者中CIMO与CIMOL表达呈负相关,r=-0.47,P〈0.05。结论(1)CIM0、CIM-0L阳性率与病理类型、LDH值、全身症状密切相关,其可能与B—NHL的侵袭性及预后有关;(2)B—NHL患者中CIM0表达的增高、CIMOL表达的减少可能是影响其发病的因素之一;(3)B—NHL患者中CD40L表达的减少可能与肿瘤免疫逃逸机制有关。 Objective To explore the expressions and changing regularity of CIMO,CIMOL in surface of bone marrow mononuclear cell(BMMC) of patients with B -cell Non -Hodgkin's Lymphoma. To study the rela- tionship between the expressions of CIM0, CIMOL and the pathogenesis ,infestation ,prognosis, clinical implication of patients with Lymphoma. Methods Twenty bone marrow specimens of B - NHL ( experimental group) and twelve healthy bone marrow specimens ( contiol group) were collected. To separate mononuclear cell, we used di- rect fluorescent antibody to mark cells,the expressions of CIMO and CIMOL were determined by flow cytometry. Statistical study was done between two groups. Results ( 1 ) CIM0 positive overexpression rate in B - NHL sam- pies (45.78± 3.82) % was higher than that in normal samples ( 13.99 ± 2.20) % ( P 〈 O. O1 ) ; CIMOL positive overexpression rate in B - NHL samples ( 3.44 ±O. 88 ) % was lower than that in normal samples ( 10.64 ± 1.03 ) % (P 〈 0. O1 ). (2)There were significant correlations between the positive overexpression rates of CIM0, CIMOL and pathology category ,lactic dehydrogenase(LDH) levels ,the whole body symptoms in B -NHL patients who suffered from bone marrow involvment( P 〈 0.05 ). (3) There were negative correlations between CIMO and CIMOL expressions in B -NHL patients who suffered from bone marrow involvment( r = -0.47, P 〈 0.05 ). Conclusions (1)There are close correlations between CD40,CD40L and pathology category, LDH levels and the whole body symptoms,which can likely be correlative in judging the B -NHL prognosis and infestation. (2)High CD40 expressions and low CD40L expressions may probably be one of etiologic factors of B - NHL. ( 3 ) Low CD40L expressions may probably be related with the mechanism of tumor escape.
出处 《实用肿瘤学杂志》 CAS 2013年第6期516-522,共7页 Practical Oncology Journal
基金 黑龙江省教育厅科学技术研究项目(1154h13)
关键词 NHL B细胞型 单个核细胞 CD40 CD40L Non-Hodgkin's Lymphoma B-cell Mononuclear cell CD40 CD40L
  • 相关文献

参考文献7

  • 1Grell M,Zimmermann G,Gottfried E. Induction of cell death by tumour necrosis factor (TNF) receptor2,CD40 and CD30;a role for TNF-R1 activation byendogenous mem-brane-anchored TNF[J].J Embo,1999,(11):3034-3043.
  • 2Toutirais O,Gervais A,Cabillic F. Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro[J].{H}CLINICAL AND EXPERIMENTAL IMMUNOLOGY,2007,(02):372-377.
  • 3黄建安,顾冬梅,庄羽美,康苏娅,张学光.CD40分子在肺癌中的表达及其临床意义[J].江苏医药,2003,29(9):645-647. 被引量:5
  • 4Voorzanger-Rousselot N,Favrot M,Blay JY. Resistance to cytotoxic chemotherapay induced by CD 40 ligand in lympho-ma cells[J].{H}Blood,1998,(01):3381-3387.
  • 5Loskog AS,Fransson ME,Totterman TT. AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model[J].{H}Clinical Cancer Research,2005,(24 Ptl):8816-8821.
  • 6Ahmad M,Rees RC,Ali SA. Escape from immunother-apy:possible mechanisms that influence tumor regression/progression[J].{H}Cancer Immunology lmmunotherapy,2004,(10):844-854.
  • 7Yang L,Carbone DP. Tumor host immune interactions and dendritic cell dysfunction[J].{H}Advances in Cancer Research,2004,(01):13-27.

二级参考文献11

  • 1[1]Young LS,Eliopoulos AG,Callagher JN,et al.CD40 and epithelial cells:across the great divide.Immunol Today,1998,19:502-506.
  • 2[2]Van Kooten C,Bancherean J.Functions of CD40 on B cells,dendritic cells and other cells.Curr Opin Immunol,1997,9:330-341.
  • 3[3]Zhou ZH,Wang JF,Wang YD,et al.An agonist anti-human CD40 monoclonal antibody that induce dendritic cell formation and mature inhibits proliferation of myeloma cell line.Hybridoma,1999,18:471-478.
  • 4[4]Barnes DM,Meyer JS,Gonzalez JG,et al.Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.Breast Cancer Res Treat,1991,18:11-17.
  • 5[5]Vestal RE,Wingett LK,Kinght LK,et al.Expression of CD40 in breast,colon,lung and ovarian tumors.Proc Am Assoc Cancer Res,1997,38:A1550-1556.
  • 6[6]Kluth B,Hess S,EngelmanmⅡ,et al.Endothelial expression of CD40 in renal cell carcinoma.Cancer Res,1999,5:2261-2267.
  • 7[7]Altenburg A,Baldus SE,Smola H,et al.CD40 ligand-CD40 interaction induce chemokines in cervical carcinoma cells in synergism with IFNγ.J Immnol,1999,121:4140-4146.
  • 8[8]Yamada M,Shiroko T,Kawaguchi Y,et al.CD40-CD40 ligand(CD154) engagement is required but not sufficient for modulating MHC class I,ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors.Int J Cancer,2001,15;92:589-599.
  • 9[9]Ghosh M,Crocker J,Morris AG.CD40 and Bc12 expression in squamous cell carcinoma of the lung:correlation with apoptosis,survival,and other clinicopathological factors.J Pathol,1999,189:363-367.
  • 10[10]Sabel MS,Yamada M,Kawaguchi Y,et al.CD40 expression on human lung cancer correlation with metastatic spread.Cancer Immumol Immumother,2000,49:101-108.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部